With so many blue chip ASX 200 shares for investors to choose from, it can be hard to decide which ones to buy.
To help narrow things down, I have picked out two that analysts rate as buys right now. They are as follows:
CSL Limited (ASX: CSL)
The first blue chip ASX 200 share that is highly rated is CSL.
CSL is one of the world's leading biotechnology companies, comprising the CSL Behring business, newly formed CSL Vifor business, and the Seqirus business.
Thanks to a combination of strong demand for its products and its material investment in research and development (R&D) each year, CSL has been growing at a solid rate for well over a decade. The good news is that these same factors are expected to support further growth in the coming years.
This will be supported by improvements in plasma collections and the company's new collection technology. The latter is designed to collect plasma more efficiently and deliver stronger yields, which could be a meaningful boost to margins.
Citi is positive on CSL and currently has a buy rating and $340.00 price target on its shares.
Goodman Group (ASX: GMG)
Another blue chip ASX 200 share to look at is Goodman Group.
This leading integrated commercial and industrial property company currently has $77.8 billion of total assets under management and over 1,700 customers globally. This includes blue chip customers such as Amazon, Coles Group Ltd (ASX: COL), DHL, and Walmart.
But it isn't settling for that. Goodman continues to build new properties and has $13.8 billion of development work in progress across 85 projects. With a yield on cost of 6.1%, these properties look likely to support solid growth in the future.
Goldman Sachs is a big fan of Goodman. It is expecting Goodman to continue its strong earnings growth in the coming years. For example, it has forecast a compound annual growth rate of ~14% between FY 2022 and FY 2024.
Goldman has a buy rating and $24.20 price target on the company's shares.
